Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
TechCrunch Industry News · TechCrunch
November 30, 20204m 44s
Audio is streamed directly from the publisher (mgln.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from among 30,000 participants in the study. Moderna also found that it was 100% effective in preventing severe cases […]
Learn more about your ad choices. Visit podcastchoices.com/adchoices